IRCT20210823052264N8 IRCT 2024-09-15 Combined Military Hospital Quetta Efficacy of itraconazole in the prevention of recurrence of Pityriasis Versicolor pityriasis versicolor PV Efficacy of itraconazole in the prevention of recurrence of Pityriasis Versicolor 2024-08-21 anticipated 144 Complete https://irct.ir/trial/78952 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention, Randomization description: All participants will receive initial treatment with itraconazole (Cap Itraconazole 100mg twice daily for 7 DAYS).Following successful initial treatment after 1 week, cured participants will be randomly assigned by lottery method to either the itraconazole group (Group A) or the placebo group (Group B).Group A will receive Cap Itraconazole 200mg twice a day in a month for 4 consecutive months and Group B will receive placebo. Participants will be assessed with scheduled follow-up visits on monthly intervals for 4 months and then after further 2 months to see sustained response. The date of any recurrence and details of the lesions or any adverse events will also be documented during follow-up visits, Blinding description: Double blinded study (participant and data analyser are blinded). 3 Pityriasis Versicolor. Intervention 1: Intervention group: Group A will receive Cap Itraconazole 200mg twice a day in a month for 4 consecutive month. Ferozsons laboratory (cap icon 100mg). Intervention 2: Control group: Group B will receive placebo once a day in a month for 4 consecutive month.Martin dow multibionata (multivitamin cap) used as placebo. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no further information